Prospectus • Nov 23, 2012
Prospectus
Open in ViewerOpens in native device viewer
Managed by Beringea LLP
If you are in any doubt as to what action you should take, you are recommended to seek your own personal financial advice immediately from your stockbroker, bank manager, solicitor, accountant or other independent financial adviser duly authorised under the Financial Services and Markets Act 2000 ("FSMA").
Your attention is drawn, in particular, to the Risk Factors set out on page 4.
| page | |
|---|---|
| Risk Factors | 4 |
| Historical Summary | 7 |
| Expected Timetable for the Offer, Enquiries and Important Notice | 7 |
| Chairman's Letter | 8 |
| Taxation | 15 |
| Terms and Conditions of Application | 18 |
| Definitions | 21 |
| Notes on how to complete the Application Form | 24 |
| Frequently Asked Questions | 25 |
| Application Form | 27 |
As a prospective Investor, there are a number of risk factors of which you should be aware before investing in New Ordinary Shares. Prospective Investors should read the whole of this Document and not rely solely on the information in the section entitled "Risk Factors". The business and financial condition of the Company could be adversely affected if any of the following risks were to occur and as a result the trading price of the New Ordinary Shares could decline and Investors could lose part or all of their investment.
The Directors consider the following risks to be material for potential Investors, but the risks listed below do not necessarily comprise all those associated with an investment in the Company and are not set out in order of priority. Additional risks and uncertainties currently unknown to the Company (such as changes in legal, regulatory or tax requirements), or which the Company currently believes are immaterial, may also have a materially adverse effect on its financial condition or prospects of the Company or the trading price of the New Ordinary Shares.
The attention of Investors is drawn specifically to the following risk factors:
newly issued shares. It may, therefore, be difficult for Shareholders to sell their New Ordinary Shares. In addition, it is likely that the market value of the New Ordinary Shares will be less than their underlying net asset value.
The Original Ordinary Shares were first Listed in April 2000. At the date of this document the Company had raised total funds of £65.7 million.
| NAV per Original Ordinary Share as at 31 August 2012 | 50.8p |
|---|---|
| NAV per consolidated Ordinary Share most recently announced to the Stock Exchange prior to the date of this document (following the one-for-two share consolidation on 30 October 2012) – Note 1 |
101.6p |
| Total dividends paid since the Company's formation per £ invested in Original Ordinary Shares at launch |
114.0p |
| Total return (NAV plus dividends paid) since the Company's formation per £ invested in Original Ordinary Shares at launch |
164.8p |
Note 1: On 29 October 2012 there was an Ordinary Share consolidation, pursuant to which holders of Original Ordinary Shares received one consolidated Ordinary Share for each two Original Ordinary Shares held prior to the consolidation. The NAV per Ordinary Share following the Ordinary Share consolidation was 101.6p, double the NAV per share prior to the consolidation.
| Offer opens | 19 November 2012 |
|---|---|
| Final date for receipt of applications through Intermediaries providing investment advice to their clients on which commission will be paid |
1pm on 21 December 2012 |
| Closing date and deadline for receipt of Applications1 | 1pm on 5 April 2013 |
| First admission | within 10 business days of the first allotment2 |
| Dealings commence | within 10 business days of each allotment2 |
| Share and tax certificates sent out | within 15 business days of each allotment2 |
1 The Offer will close earlier than the date stated above if it is fully subscribed.
2 New Ordinary Shares will be allotted and issued on 21 December 2012 in respect of successful Applications received on or before that date, and on 5 April 2013 and any other date prior to 5 April 2013 on which the Directors decide, in respect of successful Applications received after 21 December 2012 and on or before 5 April 2013.
| Beringea LLP | Tel: | 0845 686 0225 |
|---|---|---|
| 39 Earlham Street | Fax: | 020 7845 7821 |
| London | Email: [email protected] | |
| WC2H 9LT |
This Document, which constitutes a financial promotion for the purposes of section 21 of FSMA, has been approved, for the purposes of that section only, by Beringea LLP, which is authorised and regulated by the Financial Services Authority. In approving this Document, Beringea LLP is acting solely for the Company and no-one else and will not regard any other person as its customer or be responsible to anyone other than the Company for providing the protections afforded to customers of Beringea LLP or for providing advice in relation to the proposals described herein. There is no guarantee that the Company's investment objectives will be attained. If you are in any doubt as to what action to take, you should contact an independent financial adviser. The levels and bases of reliefs from taxation described in this Document are those currently available. These may change and their value depends on an Investor's individual circumstances. No person has been authorised to issue any advertisements or give any information, or make any representations in connection with the Offer, other than those contained in this Document and, if issued, given or made, such advertisements, information or representations must not be relied upon as having been authorised by the Company. This Document does not constitute either a prospectus or listing particulars.
The Board has decided to offer Investors the opportunity to subscribe for New Ordinary Shares. The funds raised under the Offer may be used to make new Qualifying Investments or to fund dividend payments, share buy-backs or operating expenses of the Company.
Investors in the Offer will gain immediate access to a more mature portfolio of investments than they would by investing in a new VCT share class and may therefore receive comparatively higher levels of dividends over the first few years of their investment. Investors will also be entitled to receive the tax benefits of investing in a VCT, subject to the usual restrictions.
The Offer will also benefit the existing Shareholders of the Company by allowing the operating costs to be spread over a larger asset base.
The investment objective for the funds raised from the Offer is to provide Investors with a total return greater than that available from direct investment in quoted businesses, by investing in a portfolio of carefully selected smaller unquoted companies with excellent growth prospects.
The Board has set an objective of paying a dividend each year which will equate to a yield of approximately 5% of net asset value. The ability to achieve this objective will, however, depend on there being sufficient reserves available for distribution, which in turn will depend on the level and timing of profitable realisations. It therefore cannot be guaranteed. The Board believes that this objective is consistent with the NAV remaining broadly stable or increasing over time, although this will depend on the returns from the Company's investments and cannot be guaranteed.
The New Ordinary Shares, once allotted, will rank with the Existing Ordinary Shares in respect of future dividend payments.
The total dividends per Share paid during a financial period may exceed the increase, if any, in the NAV per Share arising from income and realised and unrealised gains during the period. If this is the case, the NAV per Share will fall over the period.
Investors will be eligible to benefit from the significant tax advantages available for investment in VCTs, including 30% income tax relief on their initial investment (which will be forfeited if the shares are held for less than 5 years) and tax-free dividends. In addition, the sale of VCT shares is not subject to capital gains tax. The tax relief cannot exceed an amount which reduces the Investor's tax liability to nil.
The initial 30% income tax relief provides Investors with an initial investment uplift (after issue costs) of 35%. The initial uplift cannot be realised immediately, however, as the initial income tax relief will be forfeited if the New Ordinary Shares are disposed of within 5 years.
Further details of tax legislation as it relates to investors in VCTs are given in the section below entitled "Taxation".
The Company is seeking to raise, through the issue of New Ordinary Shares, a gross amount of £4 million. This is the maximum amount allowed under the UK Listing Authority's prospectus rules without the issue of a full prospectus.
New Ordinary Shares will be issued at the Offer Price calculated on the basis of the following Pricing Formula:
The most recently published NAV per Ordinary Share as at the date of this document, following the one-for-two share consolidation, is 101.6p. Based on this NAV, the New Ordinary Shares would be issued at an Offer Price of 107.5p per Share.
The Company normally announces its latest NAV per Share on a quarterly basis, with the next announcement after the date of this Document being due on or around 16 January. However, it may announce a new NAV between the normal quarterly dates if there is a material movement. Such announcements may have an upwards or downwards impact on the NAV of the Ordinary Shares and therefore on the Offer Price. Consequently, the Offer Price may change between the date on which an Investor's Application Form is posted and the date on which New Ordinary Shares in respect of that Application are allotted.
Subscription monies not used to acquire New Ordinary Shares and amounting to more than £1 will be refunded.
The New Ordinary Shares will rank equally with the Existing Ordinary Shares of the Company, including for all future dividend payments.
Investors who are shareholders in ProVen VCT as at the date of this Document will be entitled to receive additional New Ordinary Shares equivalent to 2% of the amount subscribed by them under the Offer. Investors who are shareholders in PGI VCT, ProVen Health VCT or PPE VCT as at the date of this Document will be entitled to receive additional New Ordinary Shares equivalent to 1% of the amount subscribed by them under the Offer. The subscription price for the additional New Ordinary Shares will be borne by the Investment Manager.
ProVen VCT has been managed by Beringea since the Original Ordinary Shares were first Listed in April 2000. The original Ordinary Share offer is the best performing VCT offer of its year of launch and the 6th best performing new Generalist VCT share offer ever (source: www.taxefficientreview.com – VCT performance page as at 31 October 2012, based on annual rate of return since launch).
For each £1 invested by a shareholder at the launch of the Ordinary Shares, the returns from launch to 31 August 2012 (the latest date to which results have been announced) were as follows, although prospective Investors should be aware that past performance is no guide to the future:
| First Listed | Net Asset Value | Cumulative Dividends | Total Return per £1 | Annual rate of |
|---|---|---|---|---|
| per £1 invested | paid per £1 invested | invested | return1 | |
| April 2000 | 50.8p | 114.0p | 164.8p | 8.8% |
1 Based on a net cost of 80p per share after initial income tax relief of 20%, the rate prevailing at the time.
Further details regarding the performance of each share issue by ProVen VCT can be found in the half-year accounts for the period to 31 August 2012, which are available on request from Beringea by calling 0845 686 0225 or at www.provenvcts.co.uk.
In the 12 month period ended 31 August 2012, a total dividend of 6.25p per share was paid on the Ordinary Shares, although this is no guide to future dividend payments.
On 29 October 2012 there was an Ordinary Share consolidation, pursuant to which holders of Original Ordinary Shares received one consolidated Ordinary Share for each two Original Ordinary Shares held prior to the consolidation. The NAV per Ordinary Share following the Ordinary Share consolidation was 101.6p, which was double the NAV per share prior to the consolidation. There was no change in the value of a holding of Ordinary Shares in the Company as a result of the consolidation.
Prior to the Ordinary Share consolidation the Company had three share classes: Ordinary Shares, C Shares and D Shares. Immediately following the Ordinary Share consolidation the three share classes merged, through a conversion of C Shares and D Shares into Ordinary Shares. Each C Share, which prior to the conversion had a NAV of 93.6p per C Share, converted into 0.9213 Ordinary Shares with an NAV per Ordinary Share of 101.6p. Each D Share, which prior to the conversion had a NAV of 88.6p per Share, converted into 0.8720 Ordinary Shares with an NAV per Ordinary Share of 101.6p. Each holding of C and D Shares therefore converted into a holding of Ordinary Shares of exactly the same value.
At 31 August 2012, the latest date to which results have been announced, the Company's total net assets were £45.8 million, including investments in 28 unquoted companies with an aggregate value of £28.4 million. The balance of the assets at 31 August 2012 was invested in liquidity funds and cash deposits.
Since 31 August 2012 the Company has invested £365,000 in one new unquoted company and made further investments totalling £619,000 in two existing portfolio companies.
A summary of the performance of the portfolio companies which accounted for the Company's five largest investments at 31 August 2012 is given below.
The largest Qualifying Investment in the portfolio is the investment in Think, which at 31 August 2012 was valued at £5.3 million. It therefore accounted for 11.5% of the total net asset value of the Company as at that date. Think is a strategic digital agency which provides strategic consultancy, creative design and technical build capabilities. It recently designed and created the "Pottermore" website, the on-line destination for readers of JK Rowling's "Harry Potter" series of books. The investment in Think was valued at 3.3 times cost at 31 August 2012.
The investment in Espresso Group is the Qualifying Investment with the second highest valuation in the Company's portfolio, accounting for 8.7% of the Company's net assets at 31 August 2012 and being valued at 3.0 times cost as at that date. Espresso Group is the leading provider of multimedia education content for schools, delivered over the internet. Over 9,000 UK primary schools subscribe to its flagship "Espresso for Schools" product and the company has also established a presence in the UK secondary school market. The UK business is performing well, with high renewal rates in both the primary and secondary sectors. Two years ago, Espresso launched a product for US elementary schools.
The Company's investment in Donatantonio represents 5.1% of its total net asset value and is valued at nearly 60% above cost as at 31 August 2012. Donatantonio imports and distributes high quality Mediterranean products in the UK. It has a diverse customer base, ranging from high street supermarkets and food manufacturers to retailers, wholesalers and restaurants. The company has enjoyed strong and profitable growth over the last three years.
SPC is involved in the repair and refurbishment of electronic equipment. In recent years the company has established additional operations and capacity in Thailand, India and the USA to add to the existing facilities in the UK, France and Slovakia. The Company's investment is valued at 10% above cost as at 31 August 2012 and represented 4.8% of the Company's net assets at 31 August 2012.
Fjord is a cross platform digital agency providing design and research services for companies wishing to provide services through digital platforms. It has worked on flagship products for the BBC (iplayer), Nokia (maps, Ovi) and Citibank. The company has offices in London, Helsinki, Berlin, New York, Madrid, Stockholm and San Francisco. The Company's investment in Fjord represents 4.0% of its total net asset value.
Apart from the five investments above, no Qualifying Investment represented more than 4% of the value of the Company's Net Assets at 31 August 2012.
The Qualifying Investments in the Company's portfolio are at various stages of maturity. As a result, the potential for further growth in value prior to a realisation will vary between investments.
Further information on the Company and its investment portfolio can be obtained from the Company's audited accounts for the year to 29 February 2012 and the half-year accounts for the period to 31 August 2012, which are available on request from Beringea by calling 0845 686 0225 or at www.provenvcts.co.uk.
Despite the difficult economic environment, the Investment Manager continues to see a steady flow of smaller unquoted companies seeking investment which it believes have the potential to grow rapidly. These companies generally focus on specific, high growth market sectors; they are therefore much less dependent than larger companies on the performance of the whole economy. The lack of availability of bank finance for smaller companies is another factor contributing to this strong deal flow.
Following a significant relaxation in some of the VCT investment rules earlier this year, the Company is now able to invest in a much broader range of, and larger, companies than previously. The employee limit applying to Qualifying Companies has been increased from 50 to 250 employees and the permissible gross assets following an investment have been increased from £8 million to £16 million. In addition, a company seeking investment can now raise up to £5 million of VCT or other "state-aided" investment in a 12 month period, compared to £2 million previously. These changes have made it possible for the Company to meet the investment requirements of many more companies than before.
The Investment Manager therefore believes that the prospects for it to make attractive investments on behalf of the Company are now better than they have been for some time.
The Company has been managed since launch by Beringea, an award-winning specialist in investing in small and medium sized unquoted companies. Beringea has been established for over 25 years and has managed VCTs since their inception in 1996. The investment team has over 60 years of combined investment experience in the unquoted company sector.
The Investment Manager is highly selective in making investments and has well-established processes in place to ensure a high standard of quality control. The Investment Manager also pursues a proactive approach to post-investment management including, where possible, appointing one of its executives to the board of each of the companies in which the Company invests.
The Company's investment strategy is to invest in companies with established revenue streams which meet the following criteria:
Where appropriate, the Company will invest alongside the other VCTs managed by the Investment Manager. This should enable the Company to benefit from exposure to larger businesses. The allocation of investment opportunities between the VCTs managed by the Investment Manager is governed by a co-investment policy, more details of which are given on page 13.
Prior to investing the new funds raised by the Offer in Qualifying Investments or using them to fund dividend payments, share buy-backs or operating expenses, the Company will invest them in cash, liquidity funds, fixed income securities of an A credit rating or better, or investments originated in line with the Company's investment policy for Qualifying Investments but which do not qualify under the VCT legislation for technical reasons, with the intention of generating the maximum return consistent with minimising risk to capital.
The Directors aim to provide Shareholders who wish to sell their Shares with an opportunity to do so, by operating an active policy of purchasing Shares in the market. Subject to maintaining a level of liquidity in the Company which the Directors consider sufficient for follow-on investments and operational requirements, it is the intention that the Company will buy back Ordinary Shares at a discount of no greater than 10% to the most recently announced NAV per Ordinary Share (as adjusted for any dividends paid since the announcement). The number of Ordinary Shares bought back in each year by the Company will be a maximum of 10% of the number of Ordinary Shares in issue.
The Company operates a dividend reinvestment scheme which allows Shareholders to reinvest their dividends to subscribe for additional shares. If you wish to participate in this scheme, please complete Section 5 of the Application Form. Subject to the normal limits on tax relief for investment in VCTs, the Shares obtained through this scheme should qualify for the VCT tax reliefs that are applicable to subscription for new VCT shares. The detailed rules of the dividend reinvestment scheme are available from Beringea by calling 0845 686 0225 or at www.provenvcts.co.uk.
The Company provides financial, portfolio and valuation information to Shareholders on a quarterly basis through its annual and half year reports and interim management statements. Beringea also advises Shareholders about new investments and developments in the portfolios through a newsletter, normally produced twice a year. A Shareholder event is normally held once a year, at which a number of portfolio companies give presentations. This also allows Shareholders to meet the directors of the Company and the investment management team.
Beringea has agreed to meet all the costs of the Offer in return for an initial fee of 5.5% of the monies raised, together with an annual commission of 0.2% of gross funds raised for a period of five years. Out of these fees, Beringea will be responsible for paying all the costs of the Offer including, where appropriate and permissible, initial commission payable to Intermediaries, normally at a rate of either 3% or 2.5% on the amount of successful Applications submitted through them. Intermediaries who opt to receive initial commission at the rate of 2.5% will also be entitled to be paid annual trail commission by Beringea, if permissible, normally at the rate of 0.25% for up to five years.
From 1 January 2013, Intermediaries providing investment advice to retail clients will be prohibited by new rules introduced by the Financial Services Authority from receiving commissions on the financial products that they recommend. Accordingly, Beringea will not pay commission to Intermediaries who provide advice to their clients on successful Applications received after 21 December 2012. The new rules do not apply to Intermediaries who do not provide advice, so commissions will continue to be payable to Intermediaries who fall into this category on successful Applications received after 21 December 2012.
Beringea is also entitled to receive an annual investment management fee of 2% of the Company's Net Assets. However, the Annual Running Costs are capped at 3.25% of its Net Assets; any excess will either be paid by the Investment Manager or refunded to the Company by way of a reduction to the Investment Manager's fees.
In addition, as is customary in the venture capital industry, a performance incentive may be payable to the Investment Manager in the future, dependent on the Company achieving certain performance targets.
A performance incentive fee will be payable if, at the end of a financial year, the Performance Value exceeds the Hurdle. In this event the performance incentive fee will be equal to 20% of the amount by which the Performance Value exceeds the Initial Net Asset Value, multiplied by the average number of Ordinary Shares in issue during the relevant financial year, less the amount of any performance incentive fee already paid in relation to previous financial years starting after 29 February 2012 (which will not include, for the avoidance of doubt, the Residual PIF). If the New Performance Value is less than or equal to the Hurdle in any financial year, no performance incentive fee will be payable in respect of that financial year.
The incentive fee per Ordinary Share payable in relation to a financial year will be reduced, if necessary, to ensure that (i) the cumulative performance incentive fee per Ordinary Share payable in relation to financial years starting after 29 February 2012 does not exceed 20% of Cumulative Dividends per Ordinary Share paid in relation to those financial years and (ii) the Total Return per Ordinary Share is at least equal to the Hurdle.
In consideration of the Investment Manager's performance in managing the Original Ordinary Share Portfolio, a performance incentive fee linked to the profit achieved on the future disposal of two investments from this portfolio, Espresso Group Limited and Think Limited, will be payable. This performance incentive fee will be equal to 20% of the aggregate profit realised on the sale of Espresso Group Limited and Think Limited, subject to a maximum fee of £673,000 (being 20% of the aggregate unrealised profit on these investments as at 31 August 2011). All fees paid under the performance incentive arrangements will be inclusive of VAT, if applicable. In the event of a Reorganisation, the calculation of the performance incentive will be adjusted to ensure that the amount of any fee payable is unchanged. The Investment Manager will receive 91% of all fees paid under the performance incentive arrangements and Downing LLP will receive 9%.
It is not intended that the Company should have a limited life and there is no requirement for the Directors of the Company to put to Shareholders a resolution concerning the continuation of the Company as a VCT within five years of the closing date of the Offer.
It is expected that the Company may co-invest the funds raised under the Offer alongside funds from the other VCTs managed by the Investment Manager, namely PGI VCT, ProVen Health VCT and PPE VCT. In order to ensure that new investment opportunities are apportioned fairly between the VCTs, their allocation is governed by the terms of a co-investment agreement. This broadly provides that new investments which meet the Company's investment strategy will be offered first to the Company, PGI VCT and ProVen Health VCT. These investments will be apportioned to share pools in these companies in the order in which the pools were raised. For share pools of the same vintage the allocation will be in proportion to the total VCT investment value of the relevant share pools. The amount which is apportioned to each share pool will be restricted in order to ensure good portfolio diversification. A share pool will not generally be apportioned part of any new investment once its VCT qualifying percentage has reached 75%. Each follow-on investment will be offered first to those share classes that already have an investment in the target company, pro-rata to the value of their existing investments. There are also override provisions designed to ensure that each company retains its VCT qualifying status.
The Terms and Conditions of Application, which should be read in full, are set out on pages 18 to 20 of this Document.
Investors are invited to subscribe an amount in pounds sterling, rather than apply for a particular number of New Ordinary Shares. The minimum subscription amount is £5,000.
There is no maximum individual subscription level under the Offer but the maximum investment on which tax reliefs on investments in VCTs are currently available is £200,000 in each tax year.
New Ordinary Shares will normally be allocated on a first-come, first-served basis. However, the Directors reserve the absolute discretion to determine the basis of allocation. The right is reserved to reject in whole or in part and/or scale down and/or ballot any Application or any part thereof including, without limitation, Applications in respect of which any verification of identity which the Company or Receiving Agent consider may be required for the purposes of the Money Laundering Regulations has not been satisfactorily supplied. Investors and/or Intermediaries are advised to check the status of the Offer on www.provenvcts.co.uk or telephone Beringea on 0845 686 0225 to avoid submitting Applications which may be rejected because the Offer is oversubscribed.
An Application Form is attached at the back of this Document, together with explanatory notes. Completed Application Forms should be sent or hand delivered to Beringea LLP, 39 Earlham Street, London, WC2H 9LT, together with a remittance for the full amount payable in respect of the Application. The final closing date for receipt of Applications is 1pm on 21 December 2012, unless the Offer is fully subscribed earlier. The Receiving Agent will acknowledge receipt of Applications.
Application will be made to the UK Listing Authority for the New Ordinary Shares to be admitted to the premier segment of the Official List and to trading on the London Stock Exchange's main market for listed securities.
If you have any questions about the Offer please contact your financial adviser or call Beringea LLP, the Investment Manager of the Company, on 0845 686 0225 or email [email protected]. Please note that Beringea is not permitted to give investment advice.
Yours sincerely,
Andrew Davison Chairman ProVen VCT
19 November 2012
The following is only a summary of the law concerning the tax position of individual investors in VCTs. Potential Investors who are in any doubt about the taxation consequences of investing in a VCT are recommended to consult a professional adviser.
The tax reliefs set out below are available to individuals aged 18 or over who subscribe under the Offer. Whilst there is no specific limit on the amount of an individual's acquisition of shares in a VCT, tax reliefs will only be given to the extent that the total of an individual's subscriptions or other acquisitions of shares in VCTs in any tax year do not exceed £200,000. Investors who intend to invest more than £200,000 in VCTs in any one tax year should seek professional advice.
(i) Relief from income tax on investment
Income tax relief at the rate of 30% will be available on subscriptions for shares up to a maximum of £200,000 in any tax year. This relief is limited to the amount which reduces the Investor's income tax liability to nil.
The effect of this relief for an Investor subscribing £10,000 for shares is shown below:
| No VCT tax relief | 30% income tax relief | |
|---|---|---|
| Initial investment | £10,000 | £10,000 |
| 30 per cent. income tax relief | – | (£3,000) |
| Effective investment cost | £10,000 | £7,000 |
To obtain relief an Investor must subscribe on his own behalf, although the shares may subsequently be transferred to a nominee. Investments to be used as security for, or financed by, loans may not qualify for relief, depending on the circumstances.
An Investor who acquires in any tax year VCT shares having a value of up to £200,000 will not be liable to income tax on dividends paid by the VCT on those shares.
An individual purchaser of existing VCT shares in the market will be entitled to claim dividend relief (as described in paragraph (ii) above) but not relief from income tax on investment (as described in paragraph (i) above).
Relief from income tax on a subscription for VCT shares will be withdrawn if the VCT shares are disposed of (other than between spouses) within five years of issue or if the VCT loses its approval within this period.
(i) Relief from capital gains tax on the disposal of shares
A disposal by an Investor of shares will give rise to neither a chargeable gain nor an allowable loss for the purposes of UK capital gains tax. The relief is limited to the disposal of VCT shares acquired within the limit of £200,000 for any tax year.
(ii) Purchasers in the market
An individual purchaser of shares in the market will be entitled to claim relief from capital gains tax on disposal (as described in paragraph (b) (i) above).
The Company will provide to each Investor a certificate which the Investor may use to claim income tax relief, either by obtaining from HMRC an adjustment to his tax coding under the PAYE system or by waiting until the end of the tax year and using his tax return to claim relief.
Investors not resident in the UK should seek professional advice as to the consequences of making an investment in a VCT as they may be subject to tax in other jurisdictions as well as in the UK.
No taxation will be withheld at source on any income arising from the Shares and the Company assumes no responsibility for such withholding.
If a company which has been granted approval as a VCT subsequently fails to comply with the conditions for approval, approval as a VCT may be withdrawn or treated as never having been given. In these circumstances, relief from income tax on the initial investment is repayable unless loss of approval occurs more than five years after the issue of the relevant VCT shares. In addition, relief ceases to be available on any dividend paid in respect of profits or gains in any accounting period ending when VCT status has been lost and any gains on the VCT shares up to the date from which loss of VCT status is treated as taking effect will be exempt, but gains thereafter will be taxable.
To qualify as a VCT, a company must be approved as such by HMRC. To obtain such approval it must:
A Qualifying Investment consists of shares or securities first issued to the VCT (and held by it ever since) by a company satisfying certain conditions. The conditions are detailed but include that the company must be a Qualifying Company, have gross assets not exceeding £15 million immediately before and £16 million immediately after the investment, apply the money raised for the purposes of a Qualifying Trade within certain time periods and not be controlled by another company. In any twelve month period the company can receive
no more than £5 million from state aided funds, including VCTs and the Enterprise Investment Scheme. The company must have fewer than 250 full time (or equivalent) employees at the time of making the investment. In certain circumstances, an investment in a company by a VCT can be split into part Qualifying Investment and part non-Qualifying Investment.
A Qualifying Company must be unquoted (for VCT purposes this includes companies whose shares are traded on the PLUS market and the Alternative Investment Market) and must carry on a Qualifying Trade. For this purpose certain activities are excluded (such as dealing in land or shares or providing financial services). The Qualifying Trade must either be carried on by, or be intended to be carried on by, the Qualifying Company or by a Relevant Qualifying Subsidiary (see below) at the time of the issue of shares or securities to the VCT (and at all times thereafter). A Qualifying Company must have a permanent establishment in the UK. A company intending to carry on a Qualifying Trade must begin to trade within two years of the issue of shares or securities to the VCT and continue it thereafter.
A Qualifying Company may have no subsidiaries other than Qualifying Subsidiaries which must be more than 50% owned. A Relevant Qualifying Subsidiary can be a 90% directly held subsidiary of the company invested in, its wholly owned subsidiary, or a 90% owned subsidiary of a directly held holly owned subsidiary.
A VCT must be approved at all times by HMRC. Approval has effect from the time specified in the approval. A VCT cannot be approved unless the tests detailed above are met throughout the most recent complete accounting period of the VCT and HMRC is satisfied that they will be met in relation to the accounting period of the VCT which is current when the application is made. However, in order to facilitate the launch of a VCT, HMRC may approve a VCT notwithstanding that certain of the tests are not met at the time of application, provided HMRC is satisfied that the tests will be met within certain time limits. In particular, in the case of the tests described at 2.i (d), (e) and (f) above, approval may be given if HMRC is satisfied that this will be met throughout an accounting period of the VCT beginning no more than three years after the date on which approval takes effect.
The Directors intend to conduct the affairs of the Company so that it continues to satisfy the conditions for approval as a VCT and that such approval will be maintained. HMRC has granted the Company approval under section 274 ITA as a VCT. The Company intends to comply with section 274 ITA and has retained PricewaterhouseCoopers LLP to advise it on VCT taxation matters.
Approval of a VCT may be withdrawn by HMRC if the various tests set out above are not satisfied. Withdrawal of approval generally has effect from the time when notice is given to the VCT but, in relation to capital gains of the VCT only, can be backdated to not earlier than the first day of the accounting period commencing immediately after the last accounting period of the VCT in which all of the tests were satisfied.
The above is only a summary of the conditions to be satisfied for a company to be treated as a VCT.
1 In these Terms and Conditions which apply to all Applications pursuant to the Offer, save where the context otherwise requires, words and expressions defined in this Document have the same meanings when used in these Terms and Conditions, the Application Form and the explanatory notes in relation thereto.
The minimum Application Amount is £5,000.
The contract created by the acceptance of an Application under the Offer will be conditional on Admission becoming effective.
The price at which New Ordinary Shares will be issued to an Investor (the "Offer Price") will be calculated on the basis of the following Pricing Formula:
The Offer Price is the Net Asset Value of an Ordinary Share in the Company most recently announced to the Stock Exchange, divided by 0.945 (to allow for issue costs of 5.5%), rounded up to the nearest tenth of a penny.
(iv) agree that, in respect of those New Ordinary Shares for which your Application has been received and is not rejected, your Application may be accepted at the election of the Company either by notification to the London Stock Exchange of the basis of allocation or by notification of acceptance thereof by the Receiving Agent;
(v) agree that any monies refundable to you may be retained by the Receiving Agent pending clearance of your remittance and any verification of identity which is, or which the Company or the Receiving Agent may consider to be, required for the purposes of the Money Laundering Regulations, and that such monies will not bear interest;
4 No person receiving a copy of this Document or an Application Form in any territory other than the UK may treat the same as constituting an invitation or offer to him, nor should he in any event use such Application Form unless, in the relevant territory, such an invitation or offer could lawfully be made to him or such Application Form could lawfully be used without contravention of any regulations or other legal requirements. It is the responsibility of any person outside the UK wishing to make an Application to satisfy himself as to full observance of the laws of any relevant territory in connection therewith, including obtaining any requisite governmental or other consents, observing any other formalities requiring to be observed in such territory and paying any issue, transfer or other taxes required to be paid by such territory.
5 The New Ordinary Shares have not been and will not be registered under the Securities Act, as amended, and may not be offered or sold in the United States of America, its territories or possessions or other areas subject to its jurisdiction (the "USA"). In addition, the Company has not been and will not be registered under the United States Investment Company Act of 1940, as amended. The Investment Manager will not be registered under the United States Investment Advisers Act of 1940, as amended. No application will be accepted if it bears an address in the USA.
Beringea will maintain a register of Intermediaries entitled to trail commission. Beringea will be entitled to rely on a notification from an Investor that he has changed his Intermediary, in which case the trail commission will cease to be payable to the original Intermediary and will be payable to the new Intermediary. Intermediaries should keep a record of Application Forms submitted bearing their stamp to substantiate any claim for trail commission.
Beringea LLP will collate the Application Forms bearing the Intermediaries' stamps and calculate the initial commission payable which will be paid within 14 days of each allotment.
No commission will be paid in respect of Applications received after 21 December 2012 where an Intermediary has provided financial advice to the Applicant.
Important note for Application Amounts of 15,000 Euros (approximately £12,000) or more The verification of identity requirements of the Money Laundering Regulations will apply and verification of the identity of the Applicant may be required. Failure to provide the necessary evidence of identity may result in the Application being treated as invalid or in delay in confirming the Application has been accepted.
If the Application Amount exceeds 15,000 Euros (approximately £12,000 as at the date of this Document) payment should be made by means of a UK clearing bank cheque drawn in your name on an account in your name. If this is not practicable and you use a cheque drawn by a third party or a building society cheque or banker's draft, you should write your name, address and date of birth on the back of the cheque or banker's draft and:
In this Document the following words and expressions shall, unless the context requires otherwise, have the following meanings:
| "2011 Ordinary Share Offer" | the offer for subscription for Ordinary Shares as set out in a prospectus issued by the Company on 8 December 2011 |
|---|---|
| "Admission" | admission of the New Ordinary Shares issued pursuant to the Offer to the premium segment of the Official List and to trading on the London Stock Exchange's market for listed securities |
| "Annual Running Costs" | annual costs incurred by the Company in the ordinary course of its business, excluding trail commission and performance incentive fees |
| "Applicant" | an investor whose name appears in an Application Form |
| "Application" | offer to subscribe for New Ordinary Shares under the Offer made by an Applicant by completing an Application Form |
| "Application Amount" | amount (in pounds sterling) due from an Applicant in respect of his Application or such part (if any) of his Application as is accepted |
| "Application Form" | application form contained at the end of this Document |
| "Articles" | Articles of Association of the Company |
| "Beringea" | Beringea LLP or Beringea Limited (formerly known as ProVen Private Equity Limited and previously Guinness Mahon Development Capital Limited) |
| "C Share Adjustment" | the amount by which the value of the C Share Portfolio increased or decreased between 31 August 2011 and the C Share Conversion, divided by the Pro-Forma Number of Ordinary Shares (as adjusted to take account of any dividends paid on C Shares between 31 August 2011 and the C Share Conversion) |
| "C Shares " | C Shares of 25p each in the capital of the Company |
| "C Share Portfolio" | the portfolio of investments created by investing the proceeds raised from the issue of C Shares |
| the "Company" | ProVen VCT plc |
| "Cumulative Dividends" | the cumulative amount of dividends paid by the Company in relation to the financial years starting on 1 March 2012 and finishing on the 28 February of the relevant financial year |
| "D Shares" | D Shares of 1p each in the capital of the Company |
| "Directors" or "Board" | directors of the Company as at the date of this Document |
| "Document" | this document |
| "Existing Ordinary Shares" | Ordinary Shares in issue at 19 November 2012 |
| "FSA" | Financial Services Authority |
| "FSMA" | Financial Services and Markets Act 2000 |
| "Generalist VCT" | A VCT investing primarily in private companies in a range of sectors, with the primary objective of achieving a growing Total Return |
| "HMRC" | HM Revenue & Customs |
| "Hurdle" | the greater of: (i) 1.25 times the Initial Net Asset Value, and (ii) the Initial Net Asset Value increased, as from 31 August 2011, by the Bank of England base rate plus 1% per annum (compound) |
|---|---|
| "Initial Net Asset Value" | the net asset value per Ordinary Share as at 31 August 2011 less the aggregate of the interim dividend of 6.25p per Ordinary Share paid on 2 February 2012 and the related performance incentive payment paid to the Investment Manager |
| "ITA" | Income Tax Act 2007 |
| "Intermediary" | a firm, authorised by the Financial Services Authority, through which an Applicant submits an Application |
| "Investment Manager" | Beringea LLP |
| "Investor" | an individual investor, who is a UK resident aged 18 or over, investing no more than £200,000 in VCTs in any one tax year |
| "Listed" | admitted to the premium segment of the Official List of the UK Listing Authority and to trading on the London Stock Exchange's main market for listed securities |
| "London Stock Exchange" | London Stock Exchange plc |
| "Money Laundering Regulations" | Money Laundering Regulations 2007 (as amended) |
| "NAV" | net asset value |
| "Net Assets" | gross assets less all liabilities (excluding contingent liabilities) |
| "New Ordinary Shares" | new Ordinary Shares available for subscription pursuant to the Offer |
| "Offer" or "Offer for Subscription" | offer for subscription for New Ordinary Shares pursuant to the terms of this Document |
| "Offer Price" | issue price per New Ordinary Share pursuant to the Pricing Formula |
| "Official List" | official list of the UK Listing Authority |
| "Ordinary Shares" | ordinary shares of 10p each in the capital of the Company |
| "Original Ordinary Shares" | ordinary shares of 5p each in the capital of the Company prior to the Ordinary Share consolidation that took place on 29 October 2012 |
| "Original Ordinary Share Portfolio" | the portfolio of investments created by investing the proceeds raised from the issue of Ordinary Shares prior to the 2011 Ordinary Share Offer |
| "Performance Value" | in respect of the relevant financial year end, the sum of (i) the audited net asset value per Ordinary Share at that date, (ii) all dividends per Ordinary Share paid in relation to financial years starting after 29 February 2012 up to the relevant financial year, (iii) all performance related incentive fees per Ordinary Share paid by the Company to the Manager in relation to financial years starting after 29 February 2012, (iv) any C Share Adjustment (whether relating to that or any prior financial year), and (v) any Residual PIF Adjustment (whether relating to that or any prior financial year) |
| "PGI VCT" | ProVen Growth & Income VCT plc |
| "PPE VCT" | ProVen Planned Exit VCT plc |
| "Pricing Formula" | formula for determining the price at which New Ordinary Shares will be issued to an Applicant as described in the Chairman's Letter and the Terms and Conditions |
| "Pro-Forma Number of Ordinary Shares"Additional Shares |
the pro-forma number of Ordinary Shares in issue on 31 August 2011, assuming (a) that the actual number of C Shares in issue at the date of the C Share Conversion had converted into Ordinary Shares on 31 August 2011 (using the relative net asset value per share of Ordinary Shares and C Shares on that date), and (b) that the number of Ordinary Shares in issue on 31 August 2011 included the new Ordinary Shares subsequently issued under the 2011 Ordinary Share Offer |
|---|---|
| "ProVen Health VCT" | ProVen Health VCT plc |
| "ProVen VCT" | ProVen VCT plc |
| "Qualifying Company" | a company satisfying the conditions of Chapter 4 of Part 6 ITA as described in the Taxation section of this Document |
| "Qualifying Investment" | an investment in an unquoted company which satisfies the requirements of Chapter 4 of Part 6 ITA, as described in the Taxation section of this Document |
| "Qualifying Subscriber" | an individual who subscribes for New Ordinary Shares under the Offer and is aged 18 or over and satisfies the conditions of eligibility for tax relief available to investors in a VCT |
| "Qualifying Subsidiary" | a subsidiary company which falls within the definition of Qualifying Subsidiary contained in section 302 ITA, as described in the Taxation section of this Document |
| "Qualifying Trade" | a trade complying with the requirements of Chapter 4 of Part 6 ITA |
| "Relevant Qualifying Subsidiary" | a relevant subsidiary company which falls within the definition of Relevant Qualifying Subsidiary contained in section 301 ITA, as described in the Taxation section of this Document |
| "Receiving Agent" | Beringea LLP |
| "Registrars" | Capita Registrars |
| "Residual PIF" | the performance incentive fee relating to the sale of Espresso Group Limited and Think Limited, as set out on page 13 of this Document |
| "Residual PIF Adjustment" | the "Residual PIF" divided by the number of Ordinary Shares in issue on 31 August 2011, assuming that this included the New Ordinary Shares subsequently issued under the 2011 Ordinary Share Offer, or if the C Share Conversion has not taken place, the Residual PIF divided by the Pro- Forma Number of Ordinary Shares |
| "Reorganisation" | in relation to the Company, any issue by way of capitalisation of profits or reserves or by way of rights and any consolidation or sub-division or reduction of capital or capital dividend or other reconstruction or adjustment relating to the equity share capital (or any shares, stock or securities derived therefrom) and any other amalgamation, arrangement, reconstruction or compromise affecting the share capital (or any shares, stock or securities derived therefrom) |
| "Shares" | Ordinary Shares, New Ordinary Shares, C Shares and/or D Shares |
| "Shareholders" | holders of Ordinary Shares |
| "Terms and Conditions" | terms and conditions of Application as set out on pages 18 to 20 of this Document |
| "Total Return" | the net asset value per Ordinary Share at the relevant financial year end, plus Cumulative Dividends per Ordinary Share |
| "UK Listing Authority" | Financial Services Authority acting in its capacity as the competent authority for the purposes of FSMA |
| "Venture Capital Trust" or "VCT" | a company approved as a venture capital trust under section 274 ITA by the Board of HMRC |
Please send your completed Application Form together with your cheque or banker's draft and proof of identity if required (please see paragraph 9 of the Terms and Conditions on page 20 of this Document in this regard) to:
If you have any questions on how to complete the Application Form please contact Beringea on 0845 686 0225 or 0207 845 7820. Please note for legal reasons Beringea will not be able to provide advice on the merits of the Offer or give any personal tax, investment or financial advice.
Please insert your full name and permanent address in BLOCK CAPITALS, your daytime telephone number, date of birth and national insurance number in Section 1 of the Application Form. Your national insurance number, which you will find on your pay slip, is required to ensure you obtain your income tax relief. Joint applications are not permitted, but husbands, wives and civil partners may apply separately. Please insert your email address to receive updates regarding the progress of the Company by email.
Please note that the minimum investment is £5,000.
Specify the amount you wish to invest in New Ordinary Shares in the box.
Make cheques payable to "ProVen VCT plc". Cheques must be from a recognised UK bank account and your payment must relate solely to this application.
If the value of the New Ordinary Shares applied for exceeds 15,000 Euros (approximately £12,000 as at the date of this Document) payment should be made by means of a UK clearing bank cheque drawn in your name on an account in your name. If this is not practicable and you use a cheque drawn by a third party or a building society cheque or banker's draft, you should write your name, address and date of birth on the back of the cheque or banker's draft and:
If you are an existing shareholder in ProVen VCT, PGI VCT or ProVen Health VCT, please complete this section in order to claim your additional New Ordinary Shares.
An Investor who is a shareholder in ProVen VCT as at the date of this Document will be entitled to receive additional New Ordinary Shares equivalent to 2% of the amount subscribed under the Offer. An Investor who is a shareholder in PGI VCT, ProVen Health VCT or PPE VCT as at the date of this Document will be entitled to receive additional New Ordinary Shares equivalent to 1% of the amount subscribed under the Offer. The cost of the additional New Ordinary Shares will be borne by the Investment Manager. The right is reserved not to
issue additional New Ordinary Shares to an Investor if the Company, in its sole discretion, is not satisfied that the Investor is an existing shareholder.
Read the declaration below and sign and date the Application Form.
By signing this form I HEREBY DECLARE THAT:
By signing this form on behalf of the individual whose details are shown above, I make a declaration (on behalf of such individual) on the terms of sub-paragraphs (i) to (iv) above and attach the power of attorney under which I have authority to sign on behalf of such individual.
Please complete the mandate instruction in Section 5 if you wish to participate in the Dividend Reinvestment Scheme.
Please complete the mandate instruction in Section 6 if you wish to have dividends paid directly into your bank or building society account. If any Application is not accepted in full, the balance of the Application Amount may be repaid (without interest) to the bank account specified.
Intermediaries who are entitled to receive commission should stamp and complete Section 7, giving their full name and address, telephone number and details of their authorisation under the Financial Services and Markets Act 2000. An authorised signatory must sign on behalf of the Intermediary. The right is reserved to withhold payment of commission if the Company, in its sole discretion, is not satisfied that the Intermediary is authorised.
Please complete the appropriate box to indicate which commission structure you would prefer. If you wish to waive some or all of your commission, please insert ALL or a percentage of the New Ordinary Shares in respect of which you wish commission to be waived and reinvested in additional New Ordinary Shares.
details of any additional amounts to be invested arising from the incentive for early investment or waived Intermediary commission.
Q: When will the New Ordinary Shares be allotted?
Before completing this Application Form you should read the Terms and Conditions of Application and the Notes on How to Complete the Application Form. The Offer opens on 19 November 2012 and the closing date will be 1.00 pm on 5 April 2013 (or earlier if the maximum subscription has been reached before then).
Please send this Application Form together with your cheque or bankers draft and proof of identity if required, to ProVen VCT, c/o Beringea LLP, 39 Earlham Street, London, WC2H 9LT.
| Section 1 | |||
|---|---|---|---|
| Title (Mr/Mrs/Miss/Ms/Other) | Surname | ||
| Forename(s) in full | |||
| Date of birth | National Insurance Number | ||
| order book) | (You should be able to find your NI number on a payslip, form P45 or P60, a letter from HMRC, a letter from the DWP, or pension | ||
| Permanent residential address | |||
| Postcode | |||
| Please insert your email address if you wish to receive updates regarding the progress of the Company by email | |||
| Telephone (work) | Telephone (home) | ||
| Section 2 Offer Document and the articles of association of the Company. |
I offer to subscribe the following amount for New Ordinary Shares on the Terms and Conditions of Application set out in this | ||
| The minimum Application Amount is £5,000. | £ | ||
| I ENCLOSE (A) CHEQUE(S) OR BANKER'S DRAFT(S) DRAWN ON A UK CLEARING BANK, MADE PAYABLE TO "ProVen VCT plc" | |||
| Section 3 | |||
| Please indicate if you are an existing shareholder in one of the following VCTs: | |||
| ProVen VCT plc | ProVen Growth & Income VCT plc | ||
| ProVen Health VCT plc | ProVen Planned Exit VCT plc | ||
| Section 4 | |||
| Signature | Date | ||
27
I confirm that I wish to participate in the Dividend Reinvestment Scheme for each future dividend paid on all of my Shares in ProVen VCT. By agreeing to participate in the Dividend Reinvestment Scheme I agree that any mandate which I have previously given for the payment of cash dividends directly to my Bank or Building Society account shall be suspended for so long as I remain a participant in the Scheme.
| Signature | Date | ||||
|---|---|---|---|---|---|
All dividends on Shares in the Company may be paid directly into bank and building society accounts. If you wish all future dividends on Shares in ProVen VCT to be paid into your bank or building society account, please complete the mandate instruction form below.
Dividends paid directly to your account will be paid in cleared funds on the dividend payment dates. Your bank or building society statement will identify details of the dividend as well as the dates and amounts paid.
Please forward until further notice, all dividends that may from time to time become due on any Shares now standing, or which may hereafter stand, in my name in the register of members of ProVen VCT plc to the bank account listed below. I understand that if my Application is not accepted in full, the balance of Application monies may also be repaid (without interest) to the bank account listed below.
Bank or Building Society reference number and details:
| (1) Sort Code Number |
|---|
| (2) Name of Bank/Building Society |
| Title of Branch |
| Address of Branch |
| (3) Account Number |
| (4) Signature |
| Date |
The Company, Registrars and Beringea do not accept responsibility if any details quoted by you are incorrect.
| For completion by authorised financial intermediaries only Name of firm |
Stamp | ||
|---|---|---|---|
| Address | |||
| Telephone | Fax | ||
| Name of Contact: | |||
| Preferred commission structure – Please state commission percentages under the preferred commission structure (either 3% or 2.5% plus trail) so that the percentages stated against A and B total either 3% or 2.5%, as appropriate. |
3 per cent. | 2.5 per cent. plus trail |
|
| A: Commission to be paid to authorised financial intermediary | |||
| B: Commission to be waived and invested in additional shares for your client | |||
| RDR – Please indicate which type of services you provide to clients: | Advised | Non-advised | |
| Please note that no commission will be paid in respect of Applications received after 21 December 2012 where an Intermediary has provided financial advice to the Applicant. |
|||
| Signature | Date | ||
The details set out in this Application Form should be checked carefully by the Intermediary as they supersede details given in any accompanying letters or forms
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.